基本信息
浏览量:211
职业迁徙
个人简介
Team Head and Senior Research Fellow, QIMR Berghofer
Senior Staff Specialist, Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women’s Hospital
Clinician Research Fellow, Metro North Hospital and Health Service
Medical Director, Q-Gen Cell Therapeutics, QIMR Berghofer Good Manufacturing Practice facility
Adjunct Senior Lecturer, Faculty of Medicine, University of Queensland
Adjunct Associate Professor, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology
Member of Expert Advisory Panel, Medical Research Future Fund – Stem Cell Therapies Mission
Member of Editorial Board – Clinical & Translational Immunology: An official journal of the Australasian Society for Immunology and Blood Advances: An official journal of the American Society of Hematology
Dr Tey currently leads the Translational Cancer Immunotherapy Laboratory at QIMR Berghofer Medical Research Institute. She is also a practising clinician at the Royal Brisbane and Women’s Hospital (RBWH) where she is a clinical haematologist and bone marrow transplant physician. She is QIMR Berghofer / RBWH’s scientific and clinical lead in an NHMRC Centre for Research Excellence in Blood Transplant and Cell Therapy (2018 – 2022).
Dr Tey’s areas of research are bone marrow transplantation and cellular immunotherapy. Her research in bone marrow transplantation is focused on understanding the interplay between anti-tumour immunity, viral infection and graft-versus-host disease; and the means by which these can be modulated to improve patient outcome. She currently leads an NHMRC-funded project using gene-modified regulatory T cells to treat Graft-Versus-Host Disease (GVHD). Siok is also strongly focused on novel gene-modified cellular immunotherapies, especially Chimeric Antigen Receptor (CAR) T cells, for the treatment of cancer. Her group is conducting pre-clinical research and development in novel CAR T cell therapies. She also leads a joint effort by QIMR Berghofer / RBWH to manufacture CAR T cells in-house for use in phase I clinical trials.
Senior Staff Specialist, Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women’s Hospital
Clinician Research Fellow, Metro North Hospital and Health Service
Medical Director, Q-Gen Cell Therapeutics, QIMR Berghofer Good Manufacturing Practice facility
Adjunct Senior Lecturer, Faculty of Medicine, University of Queensland
Adjunct Associate Professor, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology
Member of Expert Advisory Panel, Medical Research Future Fund – Stem Cell Therapies Mission
Member of Editorial Board – Clinical & Translational Immunology: An official journal of the Australasian Society for Immunology and Blood Advances: An official journal of the American Society of Hematology
Dr Tey currently leads the Translational Cancer Immunotherapy Laboratory at QIMR Berghofer Medical Research Institute. She is also a practising clinician at the Royal Brisbane and Women’s Hospital (RBWH) where she is a clinical haematologist and bone marrow transplant physician. She is QIMR Berghofer / RBWH’s scientific and clinical lead in an NHMRC Centre for Research Excellence in Blood Transplant and Cell Therapy (2018 – 2022).
Dr Tey’s areas of research are bone marrow transplantation and cellular immunotherapy. Her research in bone marrow transplantation is focused on understanding the interplay between anti-tumour immunity, viral infection and graft-versus-host disease; and the means by which these can be modulated to improve patient outcome. She currently leads an NHMRC-funded project using gene-modified regulatory T cells to treat Graft-Versus-Host Disease (GVHD). Siok is also strongly focused on novel gene-modified cellular immunotherapies, especially Chimeric Antigen Receptor (CAR) T cells, for the treatment of cancer. Her group is conducting pre-clinical research and development in novel CAR T cell therapies. She also leads a joint effort by QIMR Berghofer / RBWH to manufacture CAR T cells in-house for use in phase I clinical trials.
研究兴趣
论文共 97 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nature Immunologypp.1-1, (2024)
Bone Marrow Transplantationno. 1 (2024): 144-146
Edmund K. Waller,Mitchell Horwitz,Sarah Anand,Siok-Keen Tey,Mel Berger, Ralph Preiss, Aparna Raychaudhuri, Vaibhav Mahajan, Preenan Sarkar,Gautam Baheti, Melisa Cooper, Laurie Lee,
Transplantation and Cellular Therapyno. 2 (2024): S261
Adaeze Precious Ekwe,Raymond Au,Ping Zhang, Benjamin McEnroe, Mei Ling Tan,Alda Saldan,Andrea S. Henden,Cheryl Hutchins, Ashleigh Henderson, Kari Mudie, Keri Kerr, Madonna Fuery,
Cytotherapy (2024)
Ping Zhang,Peter Fleming, Christopher E Andoniou,Olivia G Waltner,Shruti S Bhise,Jose Paulo Martins, Benjamin A McEnroe,Valentina Voigt, Sheridan Daly,Rachel D Kuns, Adaeze P Ekwe,Andrea S Henden,
NATURE IMMUNOLOGY (2024)
C.J. Hutchins, A. Henderson, E.C. Lynam, M. Abaca-Cleopas, K.J. Harvey, M. Acworth,Carol S. Leung, E. Barnes, Renee J. Robb, K. Mudie, Martin J. O’Donnell, Natalie Perera,
Cytotherapyno. 6 (2023): S229-S229
引用0浏览0引用
0
0
Internal medicine journalno. 12 (2023): 2319-2329
A. Henden, K. Lineburg,L. Le Texier, J. Raju, P. Crooks, E. Wright, A. Scott, M.A. Neller,S. Tey, R. Khanna, C. Smith
Cytotherapyno. 6 (2023): S252-S252
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn